SPP1 and hepatocellular carcinoma: They identified a tumor immune barrier structure in hepatocellular carcinoma tissues, which was characterized as a spatial niche composed of SPP1+ macrophages and CAFs located near the tumor boundary that influences the efficacy of immune checkpoint blockade [49].